Skip to main content
Back
Watch Compare

Tenon Medical, Inc.

Data quality: 100%
Also listed as TNONW Nasdaq
TNON
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.77
▲ $0.03 (4.05%)
Mkt Cap: 8.26 M
Price
$0.73
Mkt Cap
8.26 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -11.02 M
Capital efficient — spends only 6.92% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)20.35%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-218.16%
Below sector avg (-53.47%)
ROIC-127.31%
Net Margin-318.36%
Op. Margin-324.34%

Safety

Debt / Equity
N/A
Current Ratio2.15
Interest Coverage-376.24

Valuation

PE (TTM)
-0.66
Above sector avg (-1.48)
P/B Ratio1.72
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.7 -1.5
P/B 1.7 1.6
ROE % -218.2 -53.5
Net Margin % -318.4 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

2 analysts
Strong Buy
Current
$0.77
+257.1%
Target
$2.75
$2.50
$2.75
$3.00
Forecast
Forward P/E -1.23
Forward EPS -$0.63
Est. Revenue 9.66 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.63
-$0.75 – -$0.50
 9.66 M 2
FY2026 -$0.88
-$1.01 – -$0.75
 6.42 M 2

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.36 -$0.22 +38.9%
Q32025 -$0.37 -$0.40 -8.1%
Q22025 -$0.47 -$0.36 +23.4%
Q12025 -$0.92 -$1.01 -9.8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 20.35% Revenue Growth (3Y) 16.06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.94 M Net Income (TTM) -12.56 M
ROE -218.16% ROA -116.91%
Gross Margin 59.79% Operating Margin -324.34%
Net Margin -318.36% Free Cash Flow (TTM) -11.02 M
ROIC -127.31% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.15
Interest Coverage -376.24 Asset Turnover 0.37
Working Capital 3.50 M Tangible Book Value 1.89 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.66 Forward P/E N/A
P/B Ratio 1.72 P/S Ratio 2.09
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -133.37%
Market Cap 8.26 M Enterprise Value 4.82 M
Per Share
EPS (Diluted TTM) -1.70 Revenue / Share 0.35
FCF / Share -0.98 OCF / Share -0.95
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6.92% FCF Conversion 87.75%
SBC-Adj. FCF -13.28 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 3.94 M 3.28 M 2.93 M 691,000.0
Net Income -12.56 M -13.67 M -15.58 M -18.92 M
EPS (Diluted) -1.70 -11.26 -8.59 -2.36
Gross Profit 2.36 M 1.71 M 1.24 M -641,000.0
Operating Income -12.79 M -13.77 M -15.73 M -18.73 M
EBITDA — — — —
R&D Expenses 2.15 M 2.60 M 3.16 M 2.83 M
SG&A Expenses — — — —
D&A 262,000.0 408,000.0 199,000.0 —
Interest Expense 34,000.0 34,000.0 21,000.0 354,000.0
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 10.76 M 9.84 M 6.35 M 11.09 M
Total Liabilities 5.72 M 3.87 M 5.57 M 4.84 M
Shareholders' Equity 5.04 M 5.97 M 778,000.0 6.25 M
Total Debt — — — —
Cash & Equivalents 3.76 M 6.54 M 2.43 M 2.13 M
Current Assets 6.77 M 8.21 M 3.89 M 9.35 M
Current Liabilities 3.21 M 1.87 M 3.14 M 2.53 M